IP Library Patent Application 18237435
Patent Application
App. No. 18/237,435

NOVEL PROCESS FOR PREPARATION OF SOLUBLE GUANYLATE CYCLASE STIMULATORS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
18/237,435
Abstract

The present disclosure relates to novel processes for the preparation of compounds useful as stimulators of soluble guanylate cyclase (sGC). These processes are amenable to large scale preparation and produce stable 3-(2-pyrimidinyl)pyrazoles of Formula (I), including Compound (I), in high purity and yields. The present invention has the additional advantage of facile reaction conditions, amenable to scale up for large scale manufacturing. The disclosure also provides novel intermediates useful in the preparation of said compounds.

Claims (67)

1 - 4 . (canceled)

5 . A process for preparing a compound of Formula III:

wherein:

R 1 is unsubstituted phenyl or 5 to 6-membered heteroaryl ring containing up to three ring heteroatoms independently selected from N, O or S;

R 2 is phenyl or a 6-membered heteroaryl, both optionally substituted with up to three instances of R 5 ; wherein said 6-membered heteroaryl ring contains up to 2 nitrogen ring atoms;

each R 5 is independently selected from C 1-6 alkyl, C 1-6 alkoxy or halogen;

R 6 is hydrogen or C 1-6 alkyl substituted with 0-3 instances of R 8 ;

R 7 is hydrogen or C 1-6 alkyl substituted with 0-3 instances of R 8 ; and

each R 8 is independently selected from —OH, C 1-3 haloalkyl or halogen;

said process comprising the steps of:

A) coupling an appropriate amount of an amine (13)

with a dichloropyrimidine (7)

in a suitable aprotic organic solvent, optionally in the presence of an appropriate amount of a suitable base, at a suitable temperature, to yield an intermediate of Formula VII,

and

B) de-chlorinating the intermediate of Formula VII with hydrogen gas or a transfer hydrogenation reagent and, optionally, an appropriate amount of a suitable metal catalyst, in the presence of an appropriate amount of a suitable base, at a suitable temperature, in a suitable organic solvent.

6 - 9 . (canceled)

10 . The process of claim 5 , wherein the process is for preparing a compound of Formula V:

wherein:

R 6 is hydrogen or C 1-6 alkyl substituted with 0-3 instances of R 8 ;

R 7 is hydrogen or C 1-6 alkyl substituted with 0-3 instances of R 8 ; and

each R 8 is independently selected from —OH, C 1-3 haloalkyl or halogen;

and wherein said process comprises the steps of:

A) coupling an appropriate amount of an amine (13)

with a dichloropyrimidine (7′)

in a suitable aprotic organic solvent, optionally in the presence of an appropriate amount of a suitable base, at a suitable temperature, to yield an intermediate of Formula VIII:

and

B) de-chlorinating the intermediate of Formula VIII with hydrogen gas or a transfer hydrogenation reagent and, optionally, an appropriate amount of a suitable metal catalyst, in the presence of an appropriate amount of a suitable base, at a suitable temperature, in a suitable organic solvent.

11 - 12 . (canceled)

13 . The process of claim 5 , wherein the process is for preparing a compound of Formula VI:

wherein:

R 1 is unsubstituted phenyl or 5 to 6-membered heteroaryl ring containing up to three ring heteroatoms independently selected from N, O or S;

R 2 is phenyl or a 6-membered heteroaryl, both optionally substituted with up to three instances of R 5 ; wherein said 6-membered heteroaryl ring contains up to 2 nitrogen ring atoms; and

each R 5 is independently selected from C 1-6 alkyl, C 1-6 alkoxy or halogen;

and wherein said process comprises the steps of:

A) coupling an appropriate amount of an amine (14)

with a dichloropyrimidine (7)

in a suitable aprotic organic solvent, optionally in the presence of an appropriate amount of a suitable base, at a suitable temperature, to yield an intermediate of Formula IX:

and

B) de-chlorinating the intermediate of Formula IX with hydrogen gas or a transfer hydrogenation reagent and, optionally, an appropriate amount of a suitable metal catalyst, in the presence of an appropriate amount of a suitable base, at a suitable temperature, in a suitable organic solvent.

14 - 15 . (canceled)

16 . The process of claim 10 , wherein the process is for preparing Compound I

and wherein said process comprises the steps of:

A) coupling an appropriate amount of an amine (14)

with a dichloropyrimidine (7′)

in a suitable aprotic organic solvent, optionally in the presence of an appropriate amount of a suitable base, at a suitable temperature, to yield an intermediate of Formula X

and

B) de-chlorinating the intermediate of Formula X with hydrogen gas or a transfer hydrogenation reagent and, optionally, an appropriate amount of a suitable metal catalyst, in the presence of an appropriate amount of a suitable base, at a suitable temperature, in a suitable organic solvent.

17 . (canceled)

18 . The process according to claim 5 , wherein R 1 is a 5-membered heteroaryl ring containing up to three heteroatoms independently selected from N, O or S.

19 . The process according to claim 18 , wherein R 1 is isoxazolyl.

20 . The process according to claim 19 , wherein R 1 is 3-isoxazolyl.

21 - 24 . (canceled)

25 . The process according to claim 5 , wherein R 2 is phenyl optionally substituted with up to three instances of R 5 .

26 . The process according to claim 25 , wherein R 2 is phenyl substituted with one instance of R 5 .

27 . The process according to claim 26 , wherein R 5 is halogen.

28 . The process according to claim 27 , wherein R 5 is fluoro.

29 - 32 . (canceled)

33 . The process according to claim 10 , wherein R 6 is hydrogen, methyl or ethyl.

34 . The process according to claim 33 , wherein R 6 is hydrogen.

35 . The process according to claim 10 , wherein R 7 is C 1-6 alkyl substituted with up to 3 instances of R 8 .

36 . The process according to claim 35 , wherein R 7 is C 1-2 alkyl, substituted with up to 3 instances of R 8 .

37 . The process according to claim 36 , wherein R 7 is ethyl, substituted with 3 instances of R 8 .

38 . The process according to claim 37 , wherein one of the three instances of R 8 is —OH.

39 . The process according to claim 37 , wherein one of the instances of R 8 is —OH and the other two instances of R 8 are C 1-3 haloalkyl.

40 . The process according to claim 39 , wherein one instance of R 8 is —OH and the other two instances of R 8 are trifluoromethyl.

41 . The process according to claim 10 , wherein one instance of R 8 is —OH.

42 . (canceled)

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 31, 2023
From: XUE, SONG; KARNATI, VISHNU VARDHAN REDDY; LIVINGSTON, ROBERT C.
To: IRONWOOD PHARMACEUTICALS, INC.
Reel/Frame 065411/0601 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 31, 2023
From: IRONWOOD PHARMACEUTICALS, INC.
To: CYCLERION THERAPEUTICS, INC.
Reel/Frame 065411/0783 →